Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Cancers|December 10, 2021
Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse GliomasGuangyang Yu, Ying Pang, Mythili Merchant, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Spatial profiling identifies regionally distinct microenvironments and targetable immunosuppressive mechanisms in pediatric osteosarcoma pulmonary metastasesJason Eigenbrood, Nathan Wong, Paul Mallory, et al.
Cell|March 25, 2021
Genetically engineered myeloid cells rebalance the core immune suppression program in metastasisSabina Kaczanowska, Daniel W Beury, Vishaka Gopalan, et al.
Cell Reports. Medicine|July 1, 2021
CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in miceNan Li, Madeline B Torres, Madeline R Spetz, et al.
Cell Reports. Medicine|April 30, 2026
Engineering functionality-optimized fully human B7-H3 CAR T cells for enhanced solid tumor therapyPradip Bajgain, Yang Feng, Mariela Puebla, et al.
Cancer Research|April 2, 2025
Spatial Profiling Identifies Regionally Distinct Microenvironments and Targetable Immunosuppressive Mechanisms in Pediatric Osteosarcoma Pulmonary MetastasesJason Eigenbrood, Nathan Wong, Paul Mallory, et al.
Nature Communications|April 30, 2015
Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturationMarianna Papaspyridonos, Irina Matei, Yujie Huang, et al.
Nature|December 13, 2005
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic nicheRosandra N Kaplan, Rebecca D Riba, Stergios Zacharoulis, et al.
Cancers|September 27, 2025
Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy BreakoutJacqueline Oliva-Ramirez, David Milewski, Lauren Banks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2023
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in RhabdomyosarcomaSrivandana Akshintala, R Taylor Sundby, Donna Bernstein, et al.
Pageof 17